Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma.

Saved in:
Bibliographic Details
Title: Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma.
Authors: Greenlund L; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States., Shanley R; Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Mulford K; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States., Neil EC; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Department of Neurology, University of Minnesota, Minneapolis, MN, United States., Lawrence J; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, MN, United States., Arnold S; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, MN, United States., Olin M; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States., Pluhar GE; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, MN, United States., Venteicher AS; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.; Department of Neurosurgery, University of Minnesota, Minneapolis, MN, United States., Chen CC; Department of Neurosurgery, University of Minnesota, Minneapolis, MN, United States., Ferreira C; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States., Reynolds M; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States., Cho LC; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States., Wilke C; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Shoo BA; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States., Yuan J; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Dusenbery K; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Kleinberg LR; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States., Terezakis SA; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States., Sloan L; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, United States.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Oct 26; Vol. 14, pp. 1284118. Date of Electronic Publication: 2023 Oct 26 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1284118